• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Implementation of a patient decision aid for men with localized prostate cancer: evaluation of patient outcomes and practice variation.为局限性前列腺癌男性患者实施患者决策辅助工具:患者结局及实践差异评估
Implement Sci. 2016 Jul 2;11(1):87. doi: 10.1186/s13012-016-0451-1.
2
A Patient Decision Aid for Men With Localized Prostate Cancer: A Comparative Case Study of Natural Implementation Approaches.局部前列腺癌男性患者决策辅助工具:自然实施方法的对比案例研究。
Cancer Nurs. 2020 Jan/Feb;43(1):E10-E21. doi: 10.1097/NCC.0000000000000651.
3
Observational study of the development and evaluation of a fertility preservation patient decision aid for teenage and adult women diagnosed with cancer: the Cancer, Fertility and Me research protocol.针对被诊断患有癌症的青少年及成年女性的生育力保存患者决策辅助工具的开发与评估的观察性研究:癌症、生育力与我研究方案
BMJ Open. 2017 Mar 13;7(3):e013219. doi: 10.1136/bmjopen-2016-013219.
4
Implementing a breast cancer patient decision aid: Process evaluation using medical files and the patients' perspective.实施乳腺癌患者决策辅助工具:使用医疗档案和患者视角进行的过程评估。
Eur J Cancer Care (Engl). 2021 Jul;30(4):e13387. doi: 10.1111/ecc.13387. Epub 2020 Dec 13.
5
Are Patient Decision Aids Used in Clinical Practice after Rigorous Evaluation? A Survey of Trial Authors.患者决策辅助工具在经过严格评估后是否在临床实践中使用?一项对试验作者的调查。
Med Decis Making. 2019 Oct;39(7):805-815. doi: 10.1177/0272989X19868193. Epub 2019 Aug 17.
6
Evaluation of a patient decision aid for initiating disease modifying anti-rheumatic drugs.一种用于启动改善病情抗风湿药物的患者决策辅助工具的评估
Arthritis Res Ther. 2016 Oct 28;18(1):252. doi: 10.1186/s13075-016-1138-3.
7
What factors influence health professionals to use decision aids for Down syndrome prenatal screening?哪些因素会影响医疗专业人员使用唐氏综合征产前筛查决策辅助工具?
BMC Pregnancy Childbirth. 2016 Sep 5;16(1):262. doi: 10.1186/s12884-016-1053-2.
8
What Is a "Good" Treatment Decision? Decisional Control, Knowledge, Treatment Decision Making, and Quality of Life in Men with Clinically Localized Prostate Cancer.什么是“好的”治疗决策?临床局限性前列腺癌男性的决策控制、知识、治疗决策制定与生活质量
Med Decis Making. 2016 Aug;36(6):714-25. doi: 10.1177/0272989X16635633. Epub 2016 Mar 8.
9
Development of a web-based patient decision aid for initiating disease modifying anti-rheumatic drugs using user-centred design methods.使用以用户为中心的设计方法开发一种基于网络的患者决策辅助工具,用于启动改善病情抗风湿药物治疗。
BMC Med Inform Decis Mak. 2017 Apr 26;17(1):51. doi: 10.1186/s12911-017-0433-5.
10
Impact of a web-based prostate cancer treatment decision aid on patient-reported decision process parameters: results from the Prostate Cancer Patient Centered Care trial.基于网络的前列腺癌治疗决策辅助工具对患者报告的决策过程参数的影响:来自前列腺癌患者为中心的护理试验的结果。
Support Care Cancer. 2018 Nov;26(11):3739-3748. doi: 10.1007/s00520-018-4236-8. Epub 2018 May 12.

引用本文的文献

1
Encouraging Patients to Ask Questions: Development and Pilot Testing of a Question Prompt List for Patients Undergoing a Biopsy for Suspected Prostate Cancer.鼓励患者提问:为疑似前列腺癌接受活检的患者制定问题提示清单的开发和初步测试。
Curr Oncol. 2023 Feb 8;30(2):2088-2104. doi: 10.3390/curroncol30020162.
2
Use of the CPD-REACTION Questionnaire to Evaluate Continuing Professional Development Activities for Health Professionals: Systematic Review.使用CPD反应问卷评估卫生专业人员的继续职业发展活动:系统评价
JMIR Med Educ. 2022 May 2;8(2):e36948. doi: 10.2196/36948.
3
Improving the Process of Shared Decision-Making by Integrating Online Structured Information and Self-Assessment Tools.通过整合在线结构化信息和自我评估工具改进共同决策过程。
J Pers Med. 2022 Feb 10;12(2):256. doi: 10.3390/jpm12020256.
4
Evaluating Clinical Implementation Approaches for Prostate Cancer Decision Support.评估前列腺癌决策支持的临床实施方法。
Urol Pract. 2019 Mar;6(2):93-99. doi: 10.1016/j.urpr.2018.05.003. Epub 2018 Mar 20.
5
Shared decision making in peri-operative medicine: Miles to go in Indian scenario.围手术期医学中的共同决策:印度的情况仍有很长的路要走。
J Anaesthesiol Clin Pharmacol. 2020 Jul-Sep;36(3):316-324. doi: 10.4103/joacp.JOACP_250_19. Epub 2020 Sep 26.
6
Decision Support Systems in Prostate Cancer Treatment: An Overview.前列腺癌治疗中的决策支持系统:概述。
Biomed Res Int. 2019 Jun 6;2019:4961768. doi: 10.1155/2019/4961768. eCollection 2019.
7
Values and preferences of men for undergoing prostate-specific antigen screening for prostate cancer: a systematic review.男性对前列腺特异性抗原筛查前列腺癌的价值观和偏好:系统评价。
BMJ Open. 2018 Sep 5;8(9):e025470. doi: 10.1136/bmjopen-2018-025470.
8
Organizational- and system-level characteristics that influence implementation of shared decision-making and strategies to address them - a scoping review.影响共享决策实施的组织和系统层面的特征及应对策略:范围综述。
Implement Sci. 2018 Mar 9;13(1):40. doi: 10.1186/s13012-018-0731-z.
9
Variation in Research Designs Used to Test the Effectiveness of Dissemination and Implementation Strategies: A Review.用于测试传播与实施策略有效性的研究设计的差异:一项综述
Front Public Health. 2018 Feb 19;6:32. doi: 10.3389/fpubh.2018.00032. eCollection 2018.
10
Reviewer training to assess knowledge translation in funding applications is long overdue.为评估资金申请中的知识转化而进行的评审培训早就该开展了。
Res Integr Peer Rev. 2017 Aug 1;2:13. doi: 10.1186/s41073-017-0037-8. eCollection 2017.

本文引用的文献

1
Implementation of a cystic fibrosis lung transplant referral patient decision aid in routine clinical practice: an observational study.在常规临床实践中实施囊性纤维化肺移植转诊患者决策辅助工具:一项观察性研究。
Implement Sci. 2015 Feb 7;10:17. doi: 10.1186/s13012-015-0206-4.
2
Patients' expectations of the benefits and harms of treatments, screening, and tests: a systematic review.患者对治疗、筛查和检测的获益和风险的期望:系统评价。
JAMA Intern Med. 2015 Feb;175(2):274-86. doi: 10.1001/jamainternmed.2014.6016.
3
Development of a simple 12-item theory-based instrument to assess the impact of continuing professional development on clinical behavioral intentions.开发一种简单的基于理论的 12 项工具,以评估继续专业发展对临床行为意向的影响。
PLoS One. 2014 Mar 18;9(3):e91013. doi: 10.1371/journal.pone.0091013. eCollection 2014.
4
"Many miles to go …": a systematic review of the implementation of patient decision support interventions into routine clinical practice.“路漫漫其修远兮……”:一项将患者决策支持干预措施融入常规临床实践中的系统评价。
BMC Med Inform Decis Mak. 2013;13 Suppl 2(Suppl 2):S14. doi: 10.1186/1472-6947-13-S2-S14. Epub 2013 Nov 29.
5
Coaching and guidance with patient decision aids: A review of theoretical and empirical evidence.辅导和指导患者决策辅助工具:理论和实证证据的回顾。
BMC Med Inform Decis Mak. 2013;13 Suppl 2(Suppl 2):S11. doi: 10.1186/1472-6947-13-S2-S11. Epub 2013 Nov 29.
6
Decision aids for people facing health treatment or screening decisions.为面临健康治疗或筛查决策的人群提供的决策辅助工具。
Cochrane Database Syst Rev. 2014 Jan 28(1):CD001431. doi: 10.1002/14651858.CD001431.pub4.
7
Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort study.前列腺癌根治性前列腺切除术或放疗后除尿失禁或勃起功能障碍以外的并发症发生率:一项基于人群的队列研究。
Lancet Oncol. 2014 Feb;15(2):223-31. doi: 10.1016/S1470-2045(13)70606-5. Epub 2014 Jan 17.
8
Validation of SURE, a four-item clinical checklist for detecting decisional conflict in patients.SURE的验证,一种用于检测患者决策冲突的四项临床检查表。
Med Decis Making. 2014 Jan;34(1):54-62. doi: 10.1177/0272989X13491463. Epub 2013 Jun 17.
9
Assessments of the extent to which health-care providers involve patients in decision making: a systematic review of studies using the OPTION instrument.对医疗服务提供者让患者参与决策程度的评估:使用OPTION工具的研究的系统评价
Health Expect. 2015 Aug;18(4):542-61. doi: 10.1111/hex.12054. Epub 2013 Mar 4.
10
Patient preference and the impact of decision-making aids on prostate cancer treatment choices and post-intervention regret.患者偏好及决策辅助工具对前列腺癌治疗选择和干预后后悔的影响。
Curr Oncol. 2012 Dec;19(Suppl 3):S37-44. doi: 10.3747/co.19.1287.

为局限性前列腺癌男性患者实施患者决策辅助工具:患者结局及实践差异评估

Implementation of a patient decision aid for men with localized prostate cancer: evaluation of patient outcomes and practice variation.

作者信息

Stacey Dawn, Taljaard Monica, Smylie Jennifer, Boland Laura, Breau Rodney H, Carley Meg, Jana Kunal, Peckford Larry, Blackmore Terry, Waldie Marian, Wu Robert Chi, Legare France

机构信息

School of Nursing, University of Ottawa, 451 Smyth Road, Ottawa, K1H 8M5, Canada.

Clinical Epidemiology Program, Ottawa Hospital Research Institute, 1053 Carling Avenue, Ottawa, ON, K1Y 4E9, Canada.

出版信息

Implement Sci. 2016 Jul 2;11(1):87. doi: 10.1186/s13012-016-0451-1.

DOI:10.1186/s13012-016-0451-1
PMID:27368830
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4930601/
Abstract

BACKGROUND

Men with localized prostate cancer often have unrealistic expectations. Practitioners are poor judges of men's preferences, contributing to preference misdiagnosis and unwarranted practice variation. Patient decision aids (PtDAs) can support men with decisions about localized prostate cancer. This is a comparative case study of two strategies for implementing PtDAs in clinical pathways for men with localized prostate cancer, evaluating (a) PtDA use; (b) impact on men, practitioners, and health system outcomes; and (c) factors influencing sustained use.

METHODS/DESIGN: Guided by the Knowledge to Action Framework, this comparative case study will be conducted using administrative data, interviews, and surveys. Cases will be bound by geographic location (one hospital in Ontario; province of Saskatchewan) and time. Eligible participants will be all men newly diagnosed with localized prostate cancer, with outcomes assessed using administrative data and interviews. Nurses, urologists, radiation oncologists, and managers will be surveyed and a smaller sample interviewed. Cases will be established for each setting with findings compared across cases. Changes in the proportions of men given the PtDA over 2 years will be determined from administrative data. Factors associated with receiving the PtDA will be explored using multivariable logistic regression analysis. To assess the impact of the PtDA, outcomes will be described using mean and standard deviation (men's decisional conflict) and frequency and proportions (practitioners consulted, uptake of treatment). To estimate the effect of the PtDA on these outcomes, adjusted mean differences and odds ratios will be calculated using exploratory multivariable general linear regression and binary or multinomial logistic regression. Factors influencing sustained PtDA use will be assessed using descriptive analysis of survey findings and thematic analysis of interview transcripts.

DISCUSSION

Determining how to embed PtDAs effectively within clinical pathways for men with localized prostate cancer is essential. PtDAs have the potential to strengthen men's active role in making prostate cancer decisions, enhance uptake of shared decision-making by practitioners, and reduce practice variation. Our team of researchers and knowledge users will use findings to improve current PtDA use and consider scaling-up implementation.

摘要

背景

患有局限性前列腺癌的男性往往抱有不切实际的期望。从业者很难判断男性的偏好,这导致了偏好误诊和不必要的医疗实践差异。患者决策辅助工具(PtDAs)可以帮助男性对局限性前列腺癌做出决策。这是一项比较案例研究,探讨在局限性前列腺癌男性患者的临床路径中实施PtDAs的两种策略,评估(a)PtDAs的使用情况;(b)对男性、从业者和卫生系统结果的影响;以及(c)影响持续使用的因素。

方法/设计:在知识转化为行动框架的指导下,本比较案例研究将使用行政数据、访谈和调查进行。案例将受地理位置(安大略省的一家医院;萨斯喀彻温省)和时间限制。符合条件的参与者将是所有新诊断为局限性前列腺癌的男性,使用行政数据和访谈评估结果。将对护士、泌尿科医生、放射肿瘤学家和管理人员进行调查,并对较小样本进行访谈。将为每个环境建立案例,并比较案例间的研究结果。通过行政数据确定两年内接受PtDAs的男性比例的变化。将使用多变量逻辑回归分析探索与接受PtDAs相关的因素。为了评估PtDAs的影响,将使用均值和标准差(男性的决策冲突)以及频率和比例(咨询的从业者、治疗的接受情况)来描述结果。为了估计PtDAs对这些结果的影响,将使用探索性多变量一般线性回归以及二元或多项逻辑回归计算调整后的均值差异和比值比。将通过对调查结果的描述性分析和访谈记录的主题分析来评估影响PtDAs持续使用的因素。

讨论

确定如何在局限性前列腺癌男性患者的临床路径中有效嵌入PtDAs至关重要。PtDAs有可能加强男性在前列腺癌决策中的积极作用,提高从业者对共同决策的接受度,并减少医疗实践差异。我们的研究人员和知识使用者团队将利用研究结果改进当前PtDAs的使用,并考虑扩大实施规模。